‘We would not want the pharmacy profession being set up to fail.’

Stakeholders have welcomed an interim TGA decision to downschedule low-dose cannabidiol to S3 – but the peak pharmacist body warns that evidence and therapeutic purpose are key The TGA has released a notice of an interim decision to amend the Poisons Standard for CBD, proposing to downschedule certain products from S4 to S3 (Pharmacist Only

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous WA winners: outstanding pharmacists recognised
Next Three vials of morphine tartrate a day